Elisa Albi

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation.

Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation.

Journal: HemaSphere
Published: July 22, 2025

Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia.

Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia.

Journal: The New England journal of medicine
Published: April 11, 2025

Loss of CYLD promotes splenic marginal zone lymphoma.

Loss of CYLD promotes splenic marginal zone lymphoma.

Journal: HemaSphere
Published: July 27, 2024

Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL.

Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL.

Journal: HemaSphere
Published: May 14, 2024

Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study.

Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study.

Journal: Hematological oncology
Published: May 26, 2023

Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.

Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.

Journal: Blood
Published: May 10, 2022

Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemia.

Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemia.

Journal: Seminars in cancer biology
Published: October 22, 2021

Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.

Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 05, 2019

NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.

NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.

Journal: Frontiers in oncology
Published: April 11, 2018

NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells.

NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells.

Journal: Frontiers in oncology
Published: January 26, 2018

Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin.

Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin.

Journal: Molecular cytogenetics
Published: October 02, 2017

Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome.

Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome.

Journal: Tumori
Published: June 10, 2017
Showing 1-12 of 12

Last Updated: 09/26/2026